Remembering John Howard Moxley III, MD |
Former UC San Diego Vice Chancellor for Health Affairs and Dean of the School of Medicine Dr. John H. Moxley III passed away on January 15th, 2024 at the age of 89. Dr. Moxley was an instrumental figure in the inception of Moores Cancer Center, and served as a member of the Moores Cancer Center board from 1993 to 2002.
|
Cell Atlases as Roadmaps in Cancer: 2024 Joint Distinguished Moores Cancer Center & UC San Diego Department of Pharmacology Annual Lecture |
Join us on Thursday, April 4, 2024 at 12:00 p.m. as Aviv Regev, PhD, discusses “Cell Atlases as Roadmaps in Cancer,” the featured topic of the 2024 annual joint distinguished lecture between Moores Cancer Center and the UC San Diego Department of Pharmacology.
|
The Complexities of Tumor Associated Macrophages and the Key to Effective Targeting for Anti-Cancer Therapy: A Talk with Immunologist Jennifer Guerriero, PhD |
Mark your calendars for Friday, April 5, from 12:00 p.m. to 1:00 p.m., as Harvard professor and immunologist, Jennifer Guerriero, PhD, discusses "The Complexities of Tumor Associated Macrophages and the Key to Effective Targeting for Anti-Cancer Therapy."
|
Tritons Belong: Addressing Antisemitism and Islamophobia |
In our continuing efforts to support our campus community, UC San Diego will engage in efforts to address Antisemitism and Islamophobia through two online learning opportunities through our Triton Belong series.
You may register to attend April’s Tritons Belong events through the links below:
Tritons Belong: Islamophobia - Addressing the Current Moment
Wednesday, April 17, 2024 | 9 to 10 a.m.
Tritons Belong: Antisemitism - Addressing the Current Moment
Wednesday, April 17, 2024 | 1 to 2 p.m.
Closed captioning, American Sign Language, and simultaneous Spanish translation services will be provided. These online events will be recorded and posted online following the event dates.
|
|
|
Krzysztof Palczewski, PhD |
March 19, 2024 | 12:00 p.m.
Leichtag Biomedical Research Building Room 107
|
March 20, 2024 | 12:00 p.m.
Comer Commons
|
March 25th, 2024 | 12:00 to 1:00 p.m.
Fishman Auditorium
|
Director’s Seminar Series |
March 27, 2024 | 12:00 p.m.
Goldberg Auditorium
|
|
|
Special Seminar Series with Dr. Shai Silberberg |
Mark your calendars for March 20 - 21 for a special seminar series featuring Dr. Shai Silberberg, Director of the Office of Research Quality at the NIH National Institute of Neurological Disorders and Stroke (NINDS). Dr. Silberberg will be giving two presentations, "Assuring a Bright Future for Biomedical Research" on March 20 and "The P-Value Pretense and Other Common Statistical Pitfalls" on March 21. There will also be an opportunity to attend a Q&A session on March 21 prior to the talk.
|
AACR/ASCO Methods in Clinical Cancer Research Workshop |
The AACR/ASCO Methods in Clinical Cancer Research Workshop is an intensive workshop in the essentials of effective clinical trial designs of therapeutic interventions in the treatment of cancer for clinical fellow and junior faculty clinical researchers in all oncology subspecialties, including radiation, surgical oncology, and radiology. Applications are due by Wednesday, March 27, 2024 at 1:00 p.m. ET.
For questions about the submission of your application online, contact Asiyah Bhallo at asiyah.bhallo@aacr.org. For all other questions about the Workshop, including eligibility, please contact Dean Post at dean.post@aacr.org.
|
Special Trainee Opportunity | Resilience in Academia: Getting Personal with Jennifer Guerriero, PhD |
Join Dr. Jennifer Guerriero on Thursday, April 4, from 10:00 a.m. to 11:00 a.m. to hear more about her journey in medicine and academia, including advice on non-linear career trajectories, mentoring, job market, personal life sacrifices, building a family during academic training, supporting peers, creating opportunities, networking, and more. There will be an additional opportunity to ask questions and enjoy lively discussion.
|
UC Women’s Initiative Applications are Now Open! |
The UC Women’s Initiative for Professional Development (UC WI) is a unique, experiential, systemwide professional development program to support the success and advancement of mid-career, woman-identified professionals. UC San Diego Campus will have 12 spaces in total to fill for the 2024-2025 virtual cohorts, along with six alternates.
Applications are accepted online beginning Feb. 26 through 12 p.m. on March 22, 2024.
|
Surgical Oncologists As Scientists (SOAS) Training Program |
As a member of the next generation of translational surgeon-scientists, you will undergo rigorous training in three disciplines: 1) the tumor microenvironment; 2) techniques of biobanking; and 3) innovation and entrepreneurship. This is a truly unique, one of a kind training program, and is located at an elite institution with a Training Faculty composed of 18 NIH-funded ($28.1 million per year; $18.5 million in direct costs) Faculty Mentors. Applications must be submitted by April 15, 2024.
|
Cancer Therapeutics Training (CT2) Training Program |
The CT2 Program is open to both MDs and PhDs and provides an intensive 2-year period of research and training in the development of novel cancer therapeutics or diagnostics at the Moores Cancer Center. Trainees not only execute a research program under the direction of a member of the faculty of this Comprehensive Cancer Center, but also participate in coursework, seminars, and lectures. Graduates of the program are prepared to transition to leadership roles in cancer therapeutics development in either an academic or commercial environment. Applications must be submitted by April 15, 2024.
|
|
|
FEATURED FUNDING OPPORTUNITIES |
Equities Grants fund research that directly addresses cancer-related health disparities in underserved populations. Areas of opportunity include socio economic, cultural, geographic, racial, or ethnic bases of discrepancies with the objective to improve prevention, detection, and treatment of cancer in medically underserved communities. This may include projects aimed at improving access to quality cancer care via increasing participation in clinical trials and other healthcare service points or the development of novel interventions and therapies that utilize community clinics, home monitoring, and digital devices/phone check-ins to maximize accessibility.
LOI Due: April 2, 2024
|
Catalyst Grants provide funding for early-stage entrepreneurs to conduct research that addresses critical challenges in cancer prevention, detection, or treatment and demonstrates opportunity to advance swiftly to clinic. Applications that translate high-quality scientific research from academia into transformative therapeutics, products, and services will be prioritized.
LOI Due: April 2, 2024
|
The Mark Foundation Emerging Leader Awards support innovative cancer research from the next generation of leaders. These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio.
LOI Due: April 29th, 2024
|
|
|
|
Immune determinants of CAR-T cell expansion in solid tumor patients receiving GD2 CAR-T cell therapy |
Catherine Hedrick, PhD (Cancer Biology and Signaling)
|
|
|
| Validating a model for predicting breast cancer and nonbreast cancer death in women aged 55 years and older |
Journal of the National Cancer Institute
|
Andrea Z LaCroix, PhD (Cancer Control Program)
|
|
|
|
Genetic risk and likelihood of prostate cancer detection on first biopsy by ancestry |
Journal of the National Cancer Institute
|
Meghana Pagadala, PhD (Structural and Functional Genomics), Tyler M Seibert, MD, PhD (Structural and Functional Genomics)
|
|
|
CLINICAL TRIALS OFFICE (CTO) |
FL115-101: First-in-Human, Phase I, Open-label, Multicenter, Dose-escalation Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of FL115 Monotherapy in Patients with Locally Advanced/Metastatic Solid Tumors |
PI: Sandip Patel, MD
NCT: NCT06130722
|
CTO TRANSFORMATION INITIATIVE |
-
As a part of our continued commitment to training, Lisa, Michelle and Kayleigh will start as Training and Education Specialists on 3/18. They will be responsible for developing role-specific trainings aimed at providing all staff with real-life insights directly from their Senior team members. Starting the last week of March, staff can expect training sessions to occur on a bi-weekly basis with all sessions recorded to be made available after the live training. If you are not able to attend these training sessions in person, please reach out to your direct supervisor .
- PI Research KPIs are in the process of implementation and faculty performance for Q1 will be reviewed starting late March / early April 2024. PI performance for clinical research activities will be rewarded with an incentive Z payment. If you are a PI and do not have a discretionary account set-up, instructions will be provided next week on how to request these accounts.
-
We have now hired 25+ NewCo positions to date, with more offers underway! See below for positions where CTO is actively recruiting. If you have interest or know of experienced candidates for these roles, we encourage you to apply and/or refer!
- The CTO Fast Lane initiative has resulted in accelerated activation of 37 trials to date through the outstanding efforts of our SWAT team – congratulations to all those involved!
|
|
|
COMMUNITY OUTREACH AND ENGAGEMENT |
Cancer Health Equity Collaborative
|
Join the Community Outreach & Engagement team next Thursday, March 27th from 10-12pm for their quarterly Cancer Healthy Equity Collaborative workgroup meeting via Zoom! This meeting will feature a presentation from San Diego County Cannabis Public Health Initiative as well as research Mateo Banegas who will share more on the breast cancer pilot project assessing social needs! Make sure to RSVP today!
Register Now
|
|
|
March 27, 2024 | 10:45 a.m. to 12:00 p.m. |
Join the Community Outreach & Engagement team on Wednesday, March 27th at the Border View YMCA (3601 Arey Drive, San Diego, CA 92154) for a special workshop dedicated to highlighting colorectal cancer awareness and screening! During this session, we'll discuss important topics such as risk factors, early detection methods, and community resources. If you'd like to join the COE team for this workshop, reach out to us at mcccoe@health.ucsd.edu!
Register Now
|
|
|
|
